IRADIMED CORPORATION — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fc16e692-9440-4ebf-a096-bf3034034b98/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $83.8M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-024691 |
| FY 2024 | $73.2M | 2024-01-01 – 2024-12-31 | evidence 0001104659-26-024691 |
| FY 2023 | $65.6M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002235 |
| FY 2022 | $53.3M | 2022-01-01 – 2022-12-31 | evidence 0001104659-23-028003 |
| FY 2021 | $41.8M | 2021-01-01 – 2021-12-31 | evidence 0001104659-22-030317 |
| FY 2020 | $31.7M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-032380 |
| FY 2019 | $38.5M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-029891 |
| FY 2018 | $7.1M | 2018-01-01 – 2018-12-31 | evidence 0001104659-19-027657 |
| FY 2017 | $23.1M | 2017-01-01 – 2017-12-31 | evidence 0001104659-19-013242 |
| FY 2016 | $32.5M | 2016-01-01 – 2016-12-31 | evidence 0001104659-19-013242 |
| FY 2015 | $31.6M | 2015-01-01 – 2015-12-31 | evidence 0001104659-16-104068 |
| FY 2014 | $15.7M | 2014-01-01 – 2014-12-31 | evidence 0001104659-15-021769 |
| FY 2013 | $11.3M | 2013-01-01 – 2013-12-31 | evidence 0001104659-15-021769 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
IRADIMED CORPORATION — all facts · Net Income · Operating Income